SCHEMBL1808795

SCHEMBL1808795

C[N]c1ccccc1S(=O)(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.44
CYP1A2 P05177 4/20 0.44
SUMO2 P61956 3/20 0.41
SUMO1 P63165 3/20 0.41
SENP7 Q9BQF6 3/20 0.41
SENP2 Q9HC62 3/20 0.41
SENP1 Q9P0U3 3/20 0.41
SENP3 Q9H4L4 1/20 0.41
TSHR P16473 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TTR P02766 2/20 0.39
FABP4 P15090 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
MAPK14 Q16539 1/20 0.39
NR4A1 P22736 1/20 0.38
ATIC P31939 1/20 0.37
POLB P06746 3/20 0.37
ALDH1A1 P00352 3/20 0.37
CTRB1 P17538 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9781572 0.83 SUMO2 (0.42) MYCCYP1A2SUMO2SUMO1SENP7
SCHEMBL3790419 0.82 CYP1A2 (0.50) MYCCYP1A2SUMO2SUMO1SENP7
SCHEMBL1804585 0.82 CYP1A2 (0.41) MYCCYP1A2SUMO2SUMO1SENP7
SCHEMBL892272 0.81 MYC (0.43) MYCCYP1A2SUMO2SUMO1SENP7
SCHEMBL7054824 0.80 ALDH1A1 (0.38) SMN1; SMN2POLBALDH1A1
SCHEMBL10788346 0.80 CYP1A2 (0.45) MYCCYP1A2SUMO2SUMO1SENP7
SCHEMBL3870157 0.80 MYC (0.41) MYCCYP1A2SUMO2SUMO1SENP7
SCHEMBL4826175 0.78 CYP1A2 (0.40) MYCCYP1A2SUMO2SUMO1SENP7
SCHEMBL343357 0.78 MYC (0.44) MYCCYP1A2SUMO2SUMO1SENP7
SCHEMBL8914222 0.78 CYP1A2 (0.40) MYCCYP1A2SUMO2SUMO1SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100221502-A1 Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2010-09-02 US claimed
US-7223301-B2 Anthrapyridone compound, water-based magenta ink composition and inkjet recording method NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2007-05-29 US claimed
US-20060219131-A1 Anthrapyridone compound, aqueous magenta ink composition and inkjet recording method NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2006-10-05 US claimed
EP-1626069-A1 ANTHRAPYRIDONE COMPOUND, AQUEOUS MAGENTA INK COMPOSITION AND INKJET RECORDING METHOD NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2006-02-15 EP claimed
US-8404036-B2 Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-03-26 US disclosed
US-20110123784-A1 WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-05-26 US disclosed
US-20100221502-A1 Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2010-09-02 US disclosed
US-7223301-B2 Anthrapyridone compound, water-based magenta ink composition and inkjet recording method NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2007-05-29 US disclosed
US-20060219131-A1 Anthrapyridone compound, aqueous magenta ink composition and inkjet recording method NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2006-10-05 US disclosed
EP-1626069-A1 ANTHRAPYRIDONE COMPOUND, AQUEOUS MAGENTA INK COMPOSITION AND INKJET RECORDING METHOD NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2006-02-15 EP disclosed
EP-0085378-B1 COPPER COMPLEX DISAZO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS HOECHST AKTIENGESELLSCHAFT (DE) 1986-03-19 EP disclosed
EP-0085378-A2 Copper complex disazo compounds, process for their preparation and their use as dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1983-08-10 EP disclosed
EP-0084849-A2 Water soluble copper complexes of disazo compounds, process for their preparation and their use as dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1983-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110123784-A1 WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME IK, RB1, COL1A1 MYC 3750/4885CYP1A2 487/4885SUMO2 3220/4885
US-20100221502-A1 Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article ABL1, ATXN2L, ANXA7 MYC 2311/4885CYP1A2 772/4885SUMO2 3287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.